Dear Editor and BBI readership,
We appreciate the correspondence from Dowd and colleagues, which informed us and BBI readers that our study (Slopen et al., 2013) using data from the National Longitudinal Study of Adolescent Health (Add Health) included individuals who were Epstein Barr Virus (EBV) seronegative. We agree with Dowd and colleagues that (1) use of EBV antibodies as an indicator of stress-related reactivation of latent herpes virus applies only to seropositive individuals, and (2) studies of psychosocial stressors and reactivation of latent herpes virus should focus exclusively on seropositive individuals. In error, we assumed that seronegative individuals did not have valid entries for EBV antibody levels in the Add Health data; for this reason, all individuals with an EBV antibody value were eligible for inclusion (range: 18-1310 au/mL). As a result, as described by Dowd and colleagues, our findings reflect both risk for EBV seropositivity and antibody response to latent infection among seropositive individuals, which introduced error into our associations of interest.
We appreciate that Dowd and colleagues have estimated a seronegative cut-off (i.e., the lowest 10% of continuous survey-weighted EBV antibody values), based on recent estimates from NHANES (Dowd et al., 2013) . The criterion for establishing seropositivity varies depending on the assay used to measure EBV antibody titers. Notably, the EBV threshold value used by Dowd and colleagues for Add Health data is much higher than a previously-reported threshold (McDade et al., 2000) , which exemplifies the importance of disseminating seropositivity threshold values at the time of data release for public-use or contractual datasets like Add Health.
Although the seronegativity threshold for Add Health has not been officially released, we have prepared tables to estimate how our results change once EBV seronegative individuals (i.e., EBV antibody values in the bottom 10%) are excluded. Associations of socioeconomic position and child maltreatment with EBV antibody levels are attenuated once seronegative individuals are excluded, and several of the associations that were significant at p < 0.05 are no longer significant. Specifically, Table 3A shows that the pattern of significant associations for the indicators of socioeconomic position remain similar, with exceptions that the association between ''some college'' and elevated EBV titers dropped to marginal significance, and the middle parental occupational status category is no longer associated with elevated EBV titers. With regard to child maltreatment (see Table 4A ), respondents who were first exposed to physical abuse at ages 3-5 years continue to have heightened EBV antibody levels both relative to those who were never abused (p<.01), and compared to those first exposed during ages 14-17 (p < 0.05). However, in contrast to our original results, models that only include seropositive individuals do not find that individuals reporting >10 occasions of sexual abuse had significantly higher EBV titers.
We thank the Editor for the opportunity to submit revised tables so that readers can observe how our results change once seronegative individuals are excluded. We have requested that these tables be linked to our original article. 
